We don't know whether the most recent response to this request contains information or not – if you are Sarai Keestra please sign in and let everyone know.

UAEM - Licensing and patenting practices of UK research institutions 2019-2020

Sarai Keestra made this Freedom of Information request to University of Warwick

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

We're waiting for Sarai Keestra to read a recent response and update the status.

Dear University of Warwick,

Dear INSERT UNIVERSITY NAME,
We have previously sent FOI requests asking for information about the licensing practices of UK universities. This was concerning the time period 18th October 2018 to 18th October 2019. We are now looking to update the information for the following year, 19th October 2019 to 19th October 2020.

The updated request is listed below:

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions
Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]
A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...
Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:
Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the period 19th October 2019 to 19th October 2020 AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the period 19th October 2019 to 19th October 2020, listed by patent family, indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event, or at another university
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other
❏ None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the period 19th October 2019 to 19th October 2020 to improve access to the technologies they license in low-and middle-income settings?

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

infocompliance, Resource, University of Warwick

Thank you for your email which has been received by the University's
Information and Data Compliance Team. 
The University undertakes to respond to Freedom of Information Requests
within 20 working days and to Data Subject Rights Requests within one
month.*

If your query is not related to a Freedom of Information Request or Data
Subject Rights Request, but is related to a data protection
matter, please redirect it to [1][email address].

Kind regards

Information and Data Compliance Team.

 

*Please note that due to the global Covid-19 pandemic, the University of
Warwick is following the advice of the UK Government and where possible
staff are working from home. New working arrangements coupled with the
prioritisation of university resources may impact upon the University’s
ability to respond to your request within the statutory timescales and you
may experience delays when making information rights requests during the
pandemic. Thank you for your patience during these unprecedented times.

References

Visible links
1. mailto:[email address]

infocompliance, Resource, University of Warwick

Dear Sarai

Thank you for submitting an FOI request, requesting information from the
University of Warwick. In order to comply with your request, we would be
grateful if you could please clarify the following:

·       Is the request made on the 4 November 2020  intended to supersede
your request sent on 27 October 2020, F054,  (which we are yet to respond
to and therefore do not need to respond to) or is this a new request in
addition to the earlier one and therefore both need responding to?

·        

Please be advised that the University will be unable to proceed with your
request until you have provided the requested clarifications and the 20
working day statutory time limit does not begin until clarification has
been received. Should we not receive a reply to this email, your request
will be closed in 20 working days.

Kind Regards

Legal and Compliance Services

 

 

infocompliance, Resource, University of Warwick

Sarai

 

The University sent the below email requesting clarification on 04
November but is yet to receive a response.

 

As it is over 20 working days since we sent our email requesting
clarification and we have not received a response, we assume you no longer
wish to pursue your request and will now close your case.

 

Kind regards,

 

Legal and Compliance Services

 

From: infocompliance, Resource <[University of Warwick request email]>
Sent: 04 November 2020 10:58
To: '[FOI #703583 email]'
<[FOI #703583 email]>
Subject: FOI Request - University of Warwick - F078.20-21

 

Dear Sarai

Thank you for submitting an FOI request, requesting information from the
University of Warwick. In order to comply with your request, we would be
grateful if you could please clarify the following:

·       Is the request made on the 4 November 2020  intended to supersede
your request sent on 27 October 2020, F054,  (which we are yet to respond
to and therefore do not need to respond to) or is this a new request in
addition to the earlier one and therefore both need responding to?

·        

Please be advised that the University will be unable to proceed with your
request until you have provided the requested clarifications and the 20
working day statutory time limit does not begin until clarification has
been received. Should we not receive a reply to this email, your request
will be closed in 20 working days.

Kind Regards

Legal and Compliance Services

 

 

Dear University of Warwick,

Thank you for the reminder. I would still like a reply to my request and I am sorry to have missed your previous email. I am not sure what you meant by the question "Is the request made on the 4 November 2020 intended to supersede your request sent on 27 October 2020, F054, (which we are yet to respond
to and therefore do not need to respond to) or is this a new request in
addition to the earlier one and therefore both need responding to?"
I do not know what request on the 27th of October 2020 F054 you were referring to, it is not part of my personal records. Therefore I would still like to request a response to "UAEM - Licensing and patenting practices of UK research institutions 2019-2020", if this is not possible because the case is closed, I can file a new FOI with the same text if this is easier for your records.
Appologies for the misunderstanding.

Yours sincerely,

Sarai Keestra

infocompliance, Resource, University of Warwick

1 Attachment

Sarai

Thank you for your email dated 04 November and 09 December 2020 requesting
information from the University of Warwick under the Freedom of
Information Act 2000. Please find below your request and the University’s
response.

FOI Request

 

We have previously sent FOI requests asking for information about the
licensing practices of UK universities. This was concerning the time
period 18th October 2018 to 18th October 2019. We are now looking to
update the information for the following year, 19th October 2019 to 19th
October 2020. 

 

The updated request is listed below:

 

For the purpose of clarity, please adhere to the following definitions
when answering these questions:

o Low and middle income country: A country that is defined as ‘low’,
‘lower-middle’ and ‘upper-middle’ income by the World Bank for the
year 2018. Income status defined by GNI per capita. Source: World
bank, available online [https://tinyurl.com/y5dwc2qv]
o A patent grants an inventor the exclusive rights to his or her
invention. A patent holder can stop other people from selling,
manufacturing, producing, or using the invention for a certain period
of time. Source: Upcouncil, available online
[https://www.upcounsel.com/what-is-a-pate...
o Licence: Permission for the licensee to use the intellectual property
rights Source: TaylorWessing, available online
[https://www.taylorwessing.com/download/a...
o Exclusive Licence: A licence that allows only the named licensee to
exploit the relevant IP rights, the licensor is also excluded from
exploiting these IP rights.
o Non-Exclusive Licence: A licence that grants any number of licensees
to exploit the IP. Source: TaylorWessing, available online
[https://www.taylorwessing.com/synapse/co...
o Health Technology: ‘Health technology as defined by the WHO: “A health
technology is the application of organized knowledge and skills in the
form of devices, medicines, vaccines, procedures and systems developed
to solve a health problem and improve quality of lives.’ Source: WHO,
available online [https://www.who.int/health-technology-as...

START FOI request:

 

 1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document.

No.

 

 2. Please provide an Excel spreadsheet with headings as displayed below
with all the health technologies LICENSED by the university in the
period 19th October 2019 to 19th October 2020 AND specify which
countries they were licensed in AND specify whether they are exclusive
or non-exclusive licenses.  Health Technology Licensed | Country of
Licensing | Type of License (Exclusive or Non-Exclusive)

Please find the information requested in the attached spreadsheet titled:
FOI Request – F078.20-21.

 

Please note, all licensing listed in the attached spreadsheet relates to
very early stage technology licensed to develop the technologies to a
stage where they will/may be useful in the future. They are not at the
stage where they are of use today.

 3. Please provide a list of patents granted to your organization in the
period 19th October 2019 to 19th October 2020, listed by patent
family, indicating countries/regions in which the patent has been
granted.

One: Assay and Medicament – Japan.

 4. In the period 19th October 2019 to 19th October 2020, has the
university shared its best practices for promoting access to medicines
through non-exclusive licensing by carrying out any of the following
activities?

·       Contributed sample clauses to the AUTM Global Health Toolkit

·       Published an article, guidance, or other literature on access
licensing practices

·       Formally presented on access licensing practices at an academic or
professional event, or at another university

·       Informally shared or discussed access licensing practices with
administrators at other universities

·       Other

·       None 

No – None.

 

 5. What actions has the technology transfer office (TTO) undertaken in
the period 19th October 2019 to 19th October 2020 to improve access to
the technologies they license in low-and middle-income settings?

None.

 

I trust that this information will be helpful to you. Should you require
any clarification, please contact me.

Yours sincerely,

Jane Furze
Director, Marketing and Communications, Regional Strategy and Warwick
Institute of Engagement
University House | Kirby Corner Road | CV4 8UW | Coventry | UK | Strategy
Group

 

We don't know whether the most recent response to this request contains information or not – if you are Sarai Keestra please sign in and let everyone know.